Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$208M |
| 2 |
Lowe's Companies
LOW
|
+$198M |
| 3 |
American Tower
AMT
|
+$161M |
| 4 |
Lennar Class A
LEN
|
+$150M |
| 5 |
British American Tobacco
BTI
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$208M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$177M |
| 3 |
Crown Castle
CCI
|
+$168M |
| 4 |
Walmart Inc
WMT
|
+$167M |
| 5 |
Entergy
ETR
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.75% |
| 2 | Technology | 13.18% |
| 3 | Healthcare | 11.51% |
| 4 | Industrials | 10.45% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
STAG Industrial
STAG
$7.14B
| $19.8M | 0.03% |
722,111
+66,937
| +10% | +$1.85M |
|
802
CALL
VanEck Gold Miners ETF
GDX
$32.2B
| $19.8M | 0.03% |
+863,800
| New | +$19.9M |
|
|
TMHC
803
DELISTED
Taylor Morrison
TMHC
| $19.8M | 0.03% |
898,630
-925,429
| -51% | -$20.4M |
|
|
GOLD
804
DELISTED
Randgold Resources Ltd
GOLD
| $19.8M | 0.03% |
202,841
-296,059
| -59% | -$28.4M |
|
|
AZUL
805
DELISTED
Azul
AZUL
| $19.8M | 0.03% |
720,521
-107,528
| -13% | -$2.75M |
|
806
BioCryst Pharmaceuticals
BCRX
$2.47B
| $19.7M | 0.03% |
3,756,165
+350,301
| +10% | +$1.79M |
|
807
United Bankshares
UBSI
$6.51B
| $19.7M | 0.03% |
529,668
+323,528
| +157% | +$11.4M |
|
808
Central Pacific Financial
CPF
$972M
| $19.7M | 0.03% |
611,287
+231,343
| +61% | +$7M |
|
809
Five Below
FIVE
$14.5B
| $19.7M | 0.03% |
358,293
-520,880
| -59% | -$25.5M |
|
810
Essent Group
ESNT
$6.15B
| $19.6M | 0.03% |
483,158
+200,003
| +71% | +$7.74M |
|
811
OraSure Technologies
OSUR
$263M
| $19.4M | 0.03% |
+864,258
| New | +$17.4M |
|
812
PUT
Medtronic
MDT
$119B
| $19.4M | 0.03% |
250,000
+100,000
| +67% | +$8.3M |
|
813
Teleflex
TFX
$5.86B
| $19.4M | 0.03% |
+80,116
| New | +$17.4M |
|
814
IPG Photonics
IPGP
$3.01B
| $19.4M | 0.03% |
+104,733
| New | +$17.4M |
|
815
Leidos
LDOS
$17.4B
| $19.3M | 0.03% |
+326,698
| New | +$18.2M |
|
816
Petrobras Class A
PBR.A
$108B
| $19.3M | 0.03% |
2,002,599
+779,250
| +64% | +$6.79M |
|
817
Yum China
YUMC
$16.7B
| $19.3M | 0.03% |
483,358
-196,099
| -29% | -$7.31M |
|
818
Kulicke & Soffa
KLIC
$4.37B
| $19.3M | 0.03% |
893,978
+498,068
| +126% | +$9.99M |
|
819
Ethan Allen Interiors
ETD
$592M
| $19.2M | 0.03% |
592,074
+579,116
| +4,469% | +$17.8M |
|
|
RDUS
820
DELISTED
Radius Health, Inc.
RDUS
| $19.2M | 0.03% |
497,420
+7,976
| +2% | +$313K |
|
821
Spectrum Brands
SPB
$2.03B
| $19.2M | 0.03% |
180,901
+142,946
| +377% | +$16.1M |
|
|
CSGS
822
DELISTED
CSG Systems International
CSGS
| $19.1M | 0.03% |
477,111
+213,843
| +81% | +$8.44M |
|
823
CALL
JD.com
JD
$39.4B
| $19.1M | 0.03% |
+500,000
| New | +$21.4M |
|
824
Jazz Pharmaceuticals
JAZZ
$16.5B
| $19.1M | 0.03% |
130,490
+93,741
| +255% | +$14.2M |
|
|
UNVR
825
DELISTED
Univar Solutions Inc.
UNVR
| $19M | 0.03% |
657,353
-576,910
| -47% | -$16.6M |
|
Similar funds
Israel Englander's Q3 2017 Portfolio in Review
As of Q3 2017, Israel Englander held 4,198 positions worth $65.6B, up 17% from $56.1B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.
Israel Englander deployed $6.37B of net new capital in Q3 2017, opening 794 new positions and adding to 1,441 existing holdings. Its largest new stake was Northern Trust: 1,591,041 shares worth $146M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $208M trimmed.
- Israel Englander's largest Q3 2017 buy was Northern Trust: 1,591,041 shares worth $146M.
- Israel Englander added most to Salesforce in Q3 2017, an estimated $208M increase.
- Israel Englander's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $208M.
- Israel Englander fully exited CONCHO RESOURCES INC. in Q3 2017, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 7.8% of its $65.6B portfolio in Q3 2017.
- Israel Englander opened 794 new positions and closed 737 in Q3 2017.
- Israel Englander's portfolio value rose 17% quarter-over-quarter to $65.6B.
Based on Millennium Management's 13F filing for Q3 2017, filed 14 Nov 2017.